Navigation Links
Linking EudraCT and ClinicalTrials.gov Records Provides Huge Benefit
Date:11/15/2011

LONDON, November 15, 2011 /PRNewswire/ --

EvaluatePharma Ltd, a leading source for life science sector analysis and the first to supply consensus forecasts of global drug sales, announced today the launch of its new clinical trial intelligence service, EP Clinical Trials[SM]. By linking EudraCT and ClinicalTrials.gov records, the new service delivers a unique synthesis of clinical trials information that will greatly benefit companies as they manage clinical trial strategies, plan clinical development programs, or seek out investment opportunities.

"Currently 52% (15,900+ trial records) of the EudraCT clinical trial data, originally released in March 2011, has been made public, and we have successfully linked half of this data via NCT-ID reference number to ClinicalTrials.gov records," said Anthony Raeside, Head of Research at EvaluatePharma®,"Our goal is to continue to make the data as meaningful and valuable as possible by indexing, linking, and revealing previously un-recognised synergies between the public clinical trial directories."

By linking the two leading sources of clinical trial records, a few examples of additional information benefit includes:

  • Enrolment numbers available for each EU country
  • Trials identified for orphan (rare disease) indications
  • Standardized technology for investigational drugs disclosed, such as biologic - gene therapy
  • Standardized pharmaceutical form such as transdermal patch
  • Ability to identify commercial company trials unique to the EudraCT site

EP Clinical Trials[SM] updated daily, also provides mapped data such as biopharmaceutical company and product information, peak and historical sales, indication, top level deal information, custom data alerts and award winning EP Vantage® commentary and analysis.

About EvaluatePharma Ltd

The research company EvaluatePharma Ltd was the first to supply consensus forecasts of global drug sales and now provides standardized worldwide financial and forecast models with consensus product sales forecasts to 2016, data on R&D pipelines, licensing deals, patent risk and M&A activity. Launched in 2007, EvaluatePharma®Alpha offers a Net Present Value (NPV) valuation service quantifying market events and the impact on product, portfolio and company valuation including the daily online news service EP Vantage®.

EvaluatePharma®, EvaluatePharma®Alpha, and EP Vantage® are services of EvaluatePharma Ltd, headquartered in London, England. In North America, EvaluatePharma Ltd is represented by EvaluatePharma USA, Inc.

http://www.evaluatepharma.com

Media Contacts:

Andrew Beaven
Marketing Director, EvaluatePharma Ltd
T: +44(0)20-7539-1818
E: andrewb@evaluatepharma.com
EvaluatePharma Ltd
11-29 Fashion Street
London
E1 6PX
United Kingdom

Christine Lindgren
EvaluatePharma USA, Inc
T: +1-617-573-9458
E: christinel@evaluatepharma.com
EvaluatePharma Ltd
15 Broad St.
Suite 401
Boston, MA
02109


'/>"/>
SOURCE EvaluatePharma Ltd
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Study Linking Increased Risk of Death to Severe Psoriasis a Call to Action
2. New Study Linking High Normal Blood Pressure to Significant Cardiovascular Risk
3. Interleukin Genetics Presents Research Linking Vertebral Fractures to Gene Variations in Asian Women With Osteoporosis
4. Glycotex, Inc. Releases Final Phase II Clinical Trials Results in the Clinicaltrials.gov Database and Announces the Results of the Mechanism of Action Study for its Product Candidate GLYC-101
5. Clinical Care Options Announces Addition of ClinicalTrials.gov Database to CCO inPractice™ Point-of-Care Resource
6. Vicus Therapeutics Records Last Patient Visit of Phase 2, VT-122 Trial for the Treatment of Cachexia in Patients With Advanced Lung Cancer
7. Aprima and MednetwoRx Partner to Provide Electronic Health Records and Remote Hosting Option to Physician Practices
8. Praxis Electronic Medical Records Announces New Version 5 With Breakthrough in EHR Documentation
9. Novalung Records 50% Growth
10. Huntington Financing Package Supports Major Regional Medical Center Electronic Medical Records Project
11. Elekta Impac Software to Demonstrate Oncology EHR Capabilities at Electronic Health Records Lab in Chicago
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... NEW YORK , Jan. 17, 2017 ... USD 8.02 billion by 2021 from USD 6.35 billion ... major factors driving the growth of this market are ... increasing demand for minimally invasive surgeries. The ... type, procedure, application, and region. On the basis of ...
(Date:1/17/2017)... , Jan. 17, 2017  Jazz Pharmaceuticals plc (Nasdaq: ... patient has been enrolled in a Phase 3 clinical ... best supportive care (BSC) in the prevention of hepatic ... hematopoietic stem cell transplant (HSCT) who are at high ... The defibrotide clinical trial will be conducted across approximately ...
(Date:1/17/2017)... 17, 2017  Market Research Future published a Half Cooked Research ... expected to reach USD 33.6 million during the period 2016 to ... ... Devices Market has been examined as a swiftly growing market and ... demand for endoscopy device in various regions.  The increasing growth in ...
Breaking Medicine Technology:
(Date:1/17/2017)... Tampa, Fla (PRWEB) , ... January 17, 2017 , ... ... IT Excellence Award for Innovation of the Year. , Each year, Pink ... has taken an innovative approach to address a specific business problem or opportunity. The ...
(Date:1/17/2017)... Clemente, CA (PRWEB) , ... January 17, 2017 ... ... Diego County, as well as Palm Desert, is opening a new office in ... Brainsway deep transcranial magnetic stimulation (dTMS) in Southern California, successfully treating individuals struggling ...
(Date:1/17/2017)... York (PRWEB) , ... January 17, 2017 , ... ... – SightMD – will lecture to primary eye care practitioners on the latest ... at the upcoming 13th Semi-Annual Continuing Education Symposium, according to eye surgeon, Jeffrey ...
(Date:1/17/2017)... ... 2017 , ... Wettstein Agencies, a Denver area firm that ... central Colorado, is joining local nonprofit Aurora Warms The Night to provide services ... is committed to breaking the cycle of homelessness and poverty affecting a growing ...
(Date:1/17/2017)... ... January 17, 2017 , ... Physicians Education Review®, LCC ... keynote speaker for the 34th Annual Miami Breast Cancer Conference®, on March 9-12, ... president, Phil Talamo, said, “We are delighted to have Sandra Lee join us ...
Breaking Medicine News(10 mins):